Clinical Trial Update: Thoracic Paravertebral Blocks Using a Combination of Ropivacaine and Dexmedetomidine [Phase 4]

View source ↗

Summary

A Phase 4 trial investigating thoracic paravertebral blocks with ropivacaine and dexmedetomidine was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thoracic Paravertebral Block-related Pain or Thoracic Analgesia

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)
• Ropivacaine (Ropivacaine)

Snippet

Sponsor: China Medical University, China | Conditions: Thoracic Paravertebral Blocks | Phase 4 | Status: WITHDRAWN